AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
PDF (1.2 MB)
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Review | Open Access

Global trends in COVID-19

Chuan-Min Zhoua,bXiang-Rong QincLi-Na YanbYuan JiangbXue-Jie Yub( )
Department of Infectious Diseases, Zhongnan Hospital, Wuhan University, Wuhan, 430071, Hubei Province, China
State Key Laboratory of Virology, School of Health Sciences, Wuhan University, Wuhan, 430071, Hubei Province, China
Department of Clinical Laboratory, the Second Hospital of Shandong University, Jinan, 250033, Shandong Province, China
Show Author Information

Abstract

The pandemic COVID-19 is certainly one of the most severe infectious diseases in human history. In the last 2 years, the COVID-19 pandemic has caused over 418.6 million confirmed cases and 5.8 million deaths worldwide. Young people make up the majority of all infected COVID-19 cases, but the mortality rate is relatively lower compared to older age groups. Currently, about 55.04% individuals have been fully vaccinated rapidly approaching to herd immunity globally. The challenge is that new SARS-CoV-2 variants with potential to evade immunity from natural infection or vaccine continue to emerge. Breakthrough infections have occurred in both SARS-CoV-2 naturally infected and vaccinated individuals, but breakthrough infections tended to exhibit mild or asymptomatic symptoms and lower mortality rates. Therefore, immunity from natural infection or vaccination can reduce SARS-CoV-2 pathogenicity, but neither can completely prevent SARS-CoV-2 infection/reinfection. Fortunately, the morbidity and mortality of COVID-19 continue to decline. The 7-day average cumulative case fatality of COVID-19 has decreased from 12.3% on the February 25, 2020, to 0.27% on January 09, 2022, which could be related to a decreased SARS-CoV-2 variant virulence, vaccine immunization, and/or better treatment of patients. In conclusion, elimination of SARS-CoV-2 in the world could be impossible or at least an arduous task with a long way to go. The best strategy to prevent COVID-19 pandemic is to expand inoculation rate of effective vaccines. As the population reaches herd immunity, the mortality rate of COVID-19 may continue to decrease, and COVID-19 could eventually become another common cold.

References

【1】
【1】
 
 
Infectious Medicine
Pages 31-39

{{item.num}}

Comments on this article

Go to comment

< Back to all reports

Review Status: {{reviewData.commendedNum}} Commended , {{reviewData.revisionRequiredNum}} Revision Required , {{reviewData.notCommendedNum}} Not Commended Under Peer Review

Review Comment

Close
Close
Cite this article:
Zhou C-M, Qin X-R, Yan L-N, et al. Global trends in COVID-19. Infectious Medicine, 2022, 1(1): 31-39. https://doi.org/10.1016/j.imj.2021.08.001

2764

Views

72

Downloads

18

Crossref

16

Web of Science

17

Scopus

Received: 07 June 2021
Revised: 23 August 2021
Accepted: 25 August 2021
Published: 04 March 2022
© The Author(s) 2022. Published by Elsevier Ltd on behalf of Tsinghua University Press.

This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/)